In This Section

Program

Please note, the tentative program for the 2021 Virtual Workshop is subject to change.  

PRE-WORKSHOP MATERIALS AND EVENTS

  • July 6-11: Workshop Pretest available
    • Completed online two weeks before start
  • July 12: Pre-recorded lectures and other materials become available on-demand
    • Biomarkers, Genetic Epidemiology, and Integrating Data on Germline Variation (Parts 1 and 2) 
      • What Is Known about the Genetic Epidemiology of Cancer (and What Is Not)
        • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
      • Publicly Available Online Genomics and ‘Omics Resources
        • Jiyeon Choi, National Cancer Institute, Bethesda, Maryland
        • Travis Gerke, The Prostate Cancer Clinical Trials Consortium (PCCTC), New York, New York
      • Mendelian Randomization
        • Paul L. Auer, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin
    • Integrating Data on Biological Function and Microbiome 
      • Leveraging GWAS to Identify Causal Variants and Genes: Fine-Mapping and Transcriptome-Wide Association Studies
        • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
      • Establishing the Functional Chain of Causation 
        • Alvaro N. A. Monteiro, Moffitt Cancer Center, Tampa, Florida
      • Overview of Epigenetics and ENCODE in a Nutshell 
        • Alvaro N. A. Monteiro, Moffitt Cancer Center, Tampa, Florida
      • Bioinformatics Toolkit for Functional Analysis (optional)
        • Jiyeon Choi, National Cancer Institute, Bethesda, Maryland
      • Microbiome (optional)
        • Carrie R. Daniel-MacDougall, UT MD Anderson Cancer Center, Houston, Texas
    • Survival Skills and Ethics
      • Case Studies and Discussion Questions 
        • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
        • Paul A. Scheet, The University of Texas MD Anderson Cancer Center, Houston, Texas
    • Precision Medicine 
      • Precision Medicine – Germline Genetics – What do we know? What do we need to know?
        • Judy E. Garber, Dana-Farber Cancer Institute, Boston, Massachusetts

LIVE VIRTUAL EVENTS 

All times listed are in U.S. Eastern Standard Time.  

Monday, July 26, 2021 – Biomarkers, Genetic Epidemiology, and Integrating Data on Germline Variation (Part 1) 

Welcome and Introduction 
10-11 a.m.  

  • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • Lorelei A. Mucci, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • Elizabeth A. Platz, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Genetic Epidemiology with Case Study 
11:30 a.m-12:30 p.m.  

  • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • Paul A. Scheet, The University of Texas MD Anderson Cancer Center, Houston, Texas

Biomarkers 
1-2:30 p.m. 

  • Shelley S. Tworoger, Moffitt Cancer Center, Tampa, Florida

Meet-the-Experts Sessions 
5-6 p.m. 

  • Judy E. Garber, Dana-Farber Cancer Institute, Boston, Massachusetts 
  • Shelley S. Tworoger, Moffitt Cancer Center, Tampa, Florida 
Tuesday, July 27, 2021 – Biomarkers, Genetic Epidemiology, and Integrating Data on Germline Variation (Part 2) 

Applied Research Seminar: Cancer Health Disparities 
10-11 a.m.  

  • Rick A. Kittles, City of Hope National Medical Center, Duarte, California

Team Science 
11:30 a.m.-12 p.m.  

  • Elizabeth A. Platz, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Publicly Available Online Genomics and ‘Omics Resources 
12:30-2 p.m. 

  • Jiyeon Choi, National Cancer Institute Shady Grove Campus, Gaithersburg, Maryland
  • Travis Gerke, The Prostate Cancer Clinical Trials Consortium (PCCTC), New York, New York

Meet-the-Experts Sessions 
3-4:30 p.m. 

  • Bogdan Pasaniuc, University of California Los Angeles, Los Angeles, California 
  • Elizabeth A. Platz, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 
  • Paul A. Scheet, UT MD Anderson Cancer Center, Houston, Texas
Wednesday, July 28, 2021 – Integrating Data on Biological Function and Microbiome 

Exome and Genome Sequencing and “Designing your population sciences gene-mapping study on a budget!” 
10-11:30 a.m.  

  • Paul A. Scheet, The University of Texas MD Anderson Cancer Center, Houston, Texas

Career Development Discussions 
12-12:30 p.m.  

Sign-ups will be available beginning July 19 

Fine Mapping
1-1:30 p.m.

  • Bogdan Pasaniuc, University of California Los Angeles, Los Angeles, California
  • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Functional Analysis Lab 
1:30-2:45 p.m. 

  • Kevin M. Brown, NCI Division. of Cancer Epidemiology & Genetics, Bethesda, Maryland
  • Jiyeon Choi, National Cancer Institute Shady Grove Campus, Gaithersburg, Maryland
  • Travis Gerke, The Prostate Cancer Clinical Trials Consortium (PCCTC), New York, New York
  • Alvaro N. Monteiro, Moffitt Cancer Center, Tampa, Florida

Microbiome 
3-4 p.m. 

  • Carrie R. Daniel-MacDougall, The University of Texas MD Anderson Cancer Center, Houston, Texas

Meet-the-Experts Sessions 
4:30-5:30 p.m. 

  • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 
  • Carrie R. Daniel-MacDougall, UT MD Anderson Cancer Center, Houston, Texas 

 

Thursday, July 29, 2021 – Survival Skills & Ethics and Overview of Tumor Profiling 

Survival Skills and Ethics (Case Studies) 
10-11 a.m.  

  • Peter Kraft, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • Paul A. Scheet, The University of Texas MD Anderson Cancer Center, Houston, Texas

Career Development Discussions 
11:30 a.m.-12 p.m.   

Sign-ups will be available beginning July 19 

Overview of Tumor Profiling, Tools, and Their Limitations 
12:30-2 p.m. 

  • Lorelei A. Mucci, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Meet-the-Experts Sessions 
3-5:00 p.m.

  • Travis Gerke, The Prostate Cancer Clinical Trials Consortium (PCCTC), New York, New York
  • Paul L. Auer, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin
  • Lorelei A. Mucci, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
  • Shelley S. Tworoger, Moffitt Cancer Center, Tampa, Florida

Joint Meet-the-Experts Session
5-5:30 p.m.

  • Kevin M. Brown, NCI Division. of Cancer Epidemiology & Genetics, Bethesda, Maryland
  • Jiyeon Choi, National Cancer Institute Shady Grove Campus, Gaithersburg, Maryland
  • Alvaro N. Monteiro, Moffitt Cancer Center, Tampa, Florida
Friday, July 30, 2021 – Precision Medicine 

Applied Research Seminar: Personalized Medicine 
10-11 a.m.  

  • Philip Kantoff, Convergent Therapeutics, Inc., Cambridge, Massachusetts

Precision Medicine: From Technology to Decision: What Does It Take? 
11:30 a.m.-12:30 p.m.  

  • Eliezer M. Van Allen, Dana-Farber Cancer Institute, Boston, Massachusetts

Precision Medicine – Predictive Modeling from High-Throughput Results: Available Tools and Issues to Consider 
1-1:30 p.m. 

  • Travis Gerke, The Prostate Cancer Clinical Trials Consortium (PCCTC), New York, New York

Data Sharing and Organization 
1:30-2 p.m. 

  • Travis Gerke, The Prostate Cancer Clinical Trials Consortium (PCCTC), New York, New York

Wrap-up and Closing 
2-2:30 p.m.